↓ Skip to main content

Dove Medical Press

The cost of schizophrenia in Japan

Overview of attention for article published in Neuropsychiatric Disease and Treatment, May 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
71 Mendeley
Title
The cost of schizophrenia in Japan
Published in
Neuropsychiatric Disease and Treatment, May 2013
DOI 10.2147/ndt.s41632
Pubmed ID
Authors

Mitsuhiro Sado, Ataru Inagaki, Akihiro Koreki, Martin Knapp, Lee Andrew Kissane, Masaru Mimura, Kimio Yoshimura

Abstract

Schizophrenia is a disorder that produces considerable burdens due to its often relapsing/remitting or chronic longitudinal course. This burden is felt not only by patients themselves, but also by their families and health care systems. Although the societal burden caused by this disorder has been evaluated in several countries, the magnitude of the societal cost of schizophrenia in Japan has never been estimated. The aim of this study is to clarify the societal burden of schizophrenia by estimating the cost of schizophrenia in Japan in 2008.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 71 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 25%
Student > Bachelor 10 14%
Student > Master 7 10%
Student > Ph. D. Student 5 7%
Student > Doctoral Student 3 4%
Other 9 13%
Unknown 19 27%
Readers by discipline Count As %
Medicine and Dentistry 11 15%
Psychology 9 13%
Economics, Econometrics and Finance 9 13%
Agricultural and Biological Sciences 5 7%
Nursing and Health Professions 4 6%
Other 8 11%
Unknown 25 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 July 2013.
All research outputs
#16,046,765
of 25,373,627 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,583
of 3,132 outputs
Outputs of similar age
#118,862
of 204,331 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#27
of 53 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,331 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.